Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow Reinvestment Rate
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow Reinvestment Rate of 0.45x as of March 2025, reinvesting Rs79.20 Million (capex Rs79.20 Million ) from operating cash flow of Rs175.81 Million. See Nath Bio-Genes (India) Limited (NATHBIOGEN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nath Bio-Genes (India) Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Nath Bio-Genes (India) Limited across 10 annual periods. For the full cash flow conversion analysis, see NATHBIOGEN cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year capital reinvestment analysis for Nath Bio-Genes (India) Limited. See financial flexibility index of Nath Bio-Genes (India) Limited to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | Rs118.82 Million | Rs175.81 Million | Rs79.20 Million | ▲ +16.1% |
| 2024 | 0.58x | Rs357.97 Million | Rs614.80 Million | Rs83.93 Million | ▲ +311.2% |
| 2023 | 0.14x | Rs54.33 Million | Rs383.67 Million | Rs25.49 Million | ▼ -88.5% |
| 2022 | 1.23x | Rs210.32 Million | Rs170.46 Million | Rs210.17 Million | ▼ -88.2% |
| 2021 | 10.47x | Rs116.49 Million | Rs11.13 Million | Rs115.98 Million | ▲ +512.0% |
| 2020 | 1.71x | Rs162.04 Million | Rs94.74 Million | Rs162.03 Million | ▲ +38.6% |
| 2017 | 1.23x | Rs41.26 Million | Rs33.43 Million | Rs41.26 Million | ▲ +1080.3% |
| 2015 | 0.10x | Rs7.06 Million | Rs67.55 Million | Rs7.06 Million | ▼ -45.7% |
| 2014 | 0.19x | Rs28.95 Million | Rs150.28 Million | Rs28.95 Million | ▼ -87.2% |
| 2013 | 1.50x | Rs213.54 Million | Rs142.11 Million | Rs213.54 Million | — |